Evidence map›Paper›PMID 30595332›Full record

ArticleNeuron2019

Harnessing Genetic Complexity to Enhance Translatability of Alzheimer's Disease Mouse Models: A Path toward Precision Medicine.

Sarah M Neuner, Sarah E Heuer, Matthew J Huentelman, Kristen M S O'Connell, Catherine C Kaczorowski

Abstract read
In one paragraph

Article in Neuron, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Sarah M NeunerThe Neuroscience Institute, University of Tennessee Health Science Center, Memphis, TN 38163, USA; The Jackson Laboratory, Bar Harbor, ME 04609, USA.
Sarah E HeuerThe Jackson Laboratory, Bar Harbor, ME 04609, USA; Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, MA 02111, USA.
Matthew J HuentelmanNeurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ 85004, USA.
Kristen M S O'ConnellThe Jackson Laboratory, Bar Harbor, ME 04609, USA.
Catherine C KaczorowskiThe Jackson Laboratory, Bar Harbor, ME 04609, USA. Electronic address: catherine.kaczorowski@jax.org.

Funding

Systems Genetics Analysis of Resilience to Alzheimers diseaseR01AG057914 · NIA · JACKSON LABORATORY · PI KACZOROWSKI, CATHERINE COOK · 2017 to 2021
$7.0M
Systems Control of Normal Aging and Alzheimer's DiseaseR01AG054180 · NIA · JACKSON LABORATORY · PI KACZOROWSKI, CATHERINE COOK · 2017 to 2021
$4.4M
Modulation of AgRP Neuronal Excitability: Role of Diet and Body WeightR01DK102918 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI O'CONNELL, KRISTEN M · 2014 to 2018
$2.0M
Identification of Genetic Modifiers of Neuronal Deficits and Memory Failure in Alzheimers DiseaseF31AG050357 · NIA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI NEUNER, SARAH M · 2015 to 2018
$171k
NIA NIH HHS F31 AG050357NIA NIH HHS R01 AG054180NIA NIH HHS R01 AG057914NIDDK NIH HHS R01 DK102918
6 · The paper itself

Abstract

An individual's genetic makeup plays a large role in determining susceptibility to Alzheimer's disease (AD) but has largely been ignored in preclinical studies. To test the hypothesis that incorporating genetic diversity into mouse models of AD would improve translational potential, we combined a well-established mouse model of AD with a genetically diverse reference panel to generate mice that harbor identical high-risk human mutations but differ across the remainder of their genome. We first show that genetic variation profoundly modifies the impact of human AD mutations on both cognitive and pathological phenotypes. We then validate this complex AD model by demonstrating high degrees of genetic, transcriptomic, and phenotypic overlap with human AD. Overall, work here both introduces a novel AD mouse population as an innovative and reproducible resource for the study of mechanisms underlying AD and provides evidence that preclinical models incorporating genetic diversity may better translate to human disease.

Indexed as

Disease Models, AnimalAlzheimer DiseaseAnimalsFemaleGenotypeMaleMiceMice, Inbred C57BLPrecision MedicineSpecies SpecificityTranslational Research, Biomedical5XFADAlzheimer’samyloidBXDgenetic diversitygenetic risk scoremouse modelsresiliencesusceptibilitytranslational

Identifiers

PMID30595332
PMCPMC6886697

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.